XL228 |
A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… |
10 mg |
21506-10 |
More Info
|
XL228 |
A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… |
25 mg |
21506-25 |
More Info
|
XL228 |
A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… |
5 mg |
21506-5 |
More Info
|
XL228 |
A tyrosine kinase inhibitor; inhibits IGF-1R and FGFR2 (IC50s = 1.6 and 50… |
50 mg |
21506-50 |
More Info
|
XL335 |
A potent and selective FXR agonist (EC50 = 4 nM in CV-1 cells transfected… |
10 mg |
23350-10 |
More Info
|
XL335 |
A potent and selective FXR agonist (EC50 = 4 nM in CV-1 cells transfected… |
25 mg |
23350-25 |
More Info
|
XL335 |
A potent and selective FXR agonist (EC50 = 4 nM in CV-1 cells transfected… |
5 mg |
23350-5 |
More Info
|
XL388 |
An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… |
10 mg |
20237-10 |
More Info
|
XL388 |
An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… |
25 mg |
20237-25 |
More Info
|
XL388 |
An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… |
5 mg |
20237-5 |
More Info
|
XL388 |
An orally bioavailable and ATP-competitive inhibitor of mTOR (IC50 = 9.9 n… |
50 mg |
20237-50 |
More Info
|
XL647 |
A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR,… |
1 mg |
27049-1 |
More Info
|
XL647 |
A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR,… |
10 mg |
27049-10 |
More Info
|
XL647 |
A multi-kinase inhibitor (IC50s = 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR,… |
5 mg |
27049-5 |
More Info
|
XL888 |
An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… |
1 mg |
16309-1 |
More Info
|
XL888 |
An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… |
10 mg |
16309-10 |
More Info
|
XL888 |
An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… |
25 mg |
16309-25 |
More Info
|
XL888 |
An ATP-competitive inhibitor of Hsp90 that causes degradation of client pr… |
5 mg |
16309-5 |
More Info
|
XL147 analog |
An analog of XL147 |
1 mg |
20245-1 |
More Info
|
XL147 analog |
An analog of XL147 |
10 mg |
20245-10 |
More Info
|
XL147 analog |
An analog of XL147 |
25 mg |
20245-25 |
More Info
|
XL147 analog |
An analog of XL147 |
5 mg |
20245-5 |
More Info
|
XL147 analog 2 |
An analog of XL147 |
1 mg |
16299-1 |
More Info
|
XL147 analog 2 |
An analog of XL147 |
10 mg |
16299-10 |
More Info
|
XL147 analog 2 |
An analog of XL147 |
5 mg |
16299-5 |
More Info
|
XL147 analog 2 |
An analog of XL147 |
50 mg |
16299-50 |
More Info
|
XL413 (hydrochloride) |
A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… |
1 mg |
24906-1 |
More Info
|
XL413 (hydrochloride) |
A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… |
10 mg |
24906-10 |
More Info
|
XL413 (hydrochloride) |
A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… |
25 mg |
24906-25 |
More Info
|
XL413 (hydrochloride) |
A potent inhibitor of Cdc7 (IC50 = 3.4 nM); >60, >10, and >300-fold select… |
5 mg |
24906-5 |
More Info
|
XLR12 |
A trifluorobutyl analog of XLR11; intended for forensic and research appli… |
1 mg |
14935-1 |
More Info
|
XLR12 |
A trifluorobutyl analog of XLR11; intended for forensic and research appli… |
10 mg |
14935-10 |
More Info
|
XLR12 |
A trifluorobutyl analog of XLR11; intended for forensic and research appli… |
5 mg |
14935-5 |
More Info
|
XLR11-d5 |
An internal standard for the quantification of XLR11 by GC- or LC-MS; regu… |
1 mg |
11771-1 |
More Info
|
XLR11-d5 |
An internal standard for the quantification of XLR11 by GC- or LC-MS; regu… |
5 mg |
11771-5 |
More Info
|
XLR11-d5 |
An internal standard for the quantification of XLR11 by GC- or LC-MS; regu… |
500 µg |
11771-500 |
More Info
|
XLR11 Degradant |
A common impurity observed during GC-MS analysis of samples containing XLR… |
1 mg |
14055-1 |
More Info
|
XLR11 Degradant |
A common impurity observed during GC-MS analysis of samples containing XLR… |
10 mg |
14055-10 |
More Info
|
XLR11 Degradant |
A common impurity observed during GC-MS analysis of samples containing XLR… |
5 mg |
14055-5 |
More Info
|
XLR11-d5 (exempt preparation) |
An internal standard for the quantification of XLR11 by GC- or LC-MS; prov… |
1 mg |
22857-1 |
More Info
|
XLR11 6-hydroxyindole metabolite |
An expected minor monohydroxylated urinary metabolite of XLR11; intended f… |
1 mg |
14354-1 |
More Info
|
XLR11 6-hydroxyindole metabolite |
An expected minor monohydroxylated urinary metabolite of XLR11; intended f… |
10 mg |
14354-10 |
More Info
|
XLR11 6-hydroxyindole metabolite |
An expected minor monohydroxylated urinary metabolite of XLR11; intended f… |
5 mg |
14354-5 |
More Info
|
XLR11 N-(2-fluoropentyl) isomer |
A variant of XLR11 with the fluorine at the 2 position rather than the 5 p… |
1 mg |
11767-1 |
More Info
|
XLR11 N-(2-fluoropentyl) isomer |
A variant of XLR11 with the fluorine at the 2 position rather than the 5 p… |
100 µg |
11767-100 |
More Info
|
XLR11 N-(2-fluoropentyl) isomer |
A variant of XLR11 with the fluorine at the 2 position rather than the 5 p… |
500 µg |
11767-500 |
More Info
|
XLR11 N-(3-fluoropentyl) isomer |
An analytical reference standard that is structurally categorized as a syn… |
1 mg |
11768-1 |
More Info
|
XLR11 N-(3-fluoropentyl) isomer |
An analytical reference standard that is structurally categorized as a syn… |
100 µg |
11768-100 |
More Info
|
XLR11 N-(3-fluoropentyl) isomer |
An analytical reference standard that is structurally categorized as a syn… |
500 µg |
11768-500 |
More Info
|
XLR11 N-(4-fluoropentyl) isomer |
An isomer of XLR11 which has the fluorine atom placed on the 4 position, r… |
1 mg |
11769-1 |
More Info
|